{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T06:30:17Z","timestamp":1788589817869,"version":"build-2803163510"},"reference-count":62,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T00:00:00Z","timestamp":1664323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.14283\/jpad.2022.77","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T10:00:13Z","timestamp":1663236013000},"page":"715-724","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Antihypertensive Agents and Incident Alzheimer's Disease: A Systematic Review and Meta-Analysis of Observational Studies"],"prefix":"10.1016","volume":"9","author":[{"given":"M.","family":"Adesuyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.H.","family":"Jani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Alsugeir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.C.L.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.S.L.","family":"Chui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.C.K.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Brauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.14283\/jpad.2022.77_bib1","author":"World Health Organization"},{"issue":"2","key":"10.14283\/jpad.2022.77_bib2","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019","volume":"7","author":"Nichols","year":"2022","journal-title":"The Lancet Public Health"},{"issue":"10248","key":"10.14283\/jpad.2022.77_bib3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission","volume":"396","author":"Livingston","year":"2020","journal-title":"Lancet"},{"key":"10.14283\/jpad.2022.77_bib4","author":"Organization WH"},{"issue":"10","key":"10.14283\/jpad.2022.77_bib5","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","article-title":"Amyloid deposition as the central event in the aetiology of Alzheimer's disease","volume":"12","author":"Hardy","year":"1991","journal-title":"Trends Pharmacol Sci"},{"issue":"7","key":"10.14283\/jpad.2022.77_bib6","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/gps.2572","article-title":"Hypertension is a potential risk factor for vascular dementia: systematic review","volume":"26","author":"Sharp","year":"2011","journal-title":"Int J Geriatr Psychiatr"},{"issue":"5","key":"10.14283\/jpad.2022.77_bib7","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1161\/HYPERTENSIONAHA.121.17797","article-title":"Association Between Blood Pressure Variability With Dementia and Cognitive Impairment: A Systematic Review and Meta-Analysis","volume":"78","author":"de Heus","year":"2021","journal-title":"Hypertension"},{"issue":"11","key":"10.14283\/jpad.2022.77_bib8","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S1474-4422(09)70236-4","article-title":"Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis","volume":"8","author":"Pendlebury","year":"2009","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.14283\/jpad.2022.77_bib9","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","article-title":"2020 International Society of Hypertension Global Hypertension Practice Guidelines","volume":"75","author":"Unger","year":"2020","journal-title":"Hypertension"},{"issue":"33","key":"10.14283\/jpad.2022.77_bib10","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J."},{"key":"10.14283\/jpad.2022.77_bib11","unstructured":"National Institute for Health and Care Excellence: Guidelines. Hypertension in adults: diagnosis and management. London: National Institute for Health and Care Excellence (NICE). Copyright \u00a9 NICE 2022.; 2022."},{"issue":"1","key":"10.14283\/jpad.2022.77_bib12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3233\/JAD-190474","article-title":"Midlife Hypertension and Alzheimer's Disease: A Systematic Review and Meta-Analysis","volume":"71","author":"Lennon","year":"2019","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"10.14283\/jpad.2022.77_bib13","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1001\/jamaneurol.2013.1342","article-title":"Risk factors for \u03b2-amyloid deposition in healthy aging: vascular and genetic effects","volume":"70","author":"Rodrigue","year":"2013","journal-title":"JAMA Neurol"},{"issue":"4","key":"10.14283\/jpad.2022.77_bib14","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1161\/HYPERTENSIONAHA.119.14033","article-title":"Blood Pressure Variability and the Risk of Dementia: A Nationwide Cohort Study","volume":"75","author":"Yoo","year":"2020","journal-title":"Hypertension"},{"issue":"4","key":"10.14283\/jpad.2022.77_bib15","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1161\/HYPERTENSIONAHA.111.178962","article-title":"Midlife blood pressure, plasma \u03b2-amyloid, and the risk for Alzheimer disease: the Honolulu Asia Aging Study","volume":"59","author":"Shah","year":"2012","journal-title":"Hypertension"},{"issue":"2","key":"10.14283\/jpad.2022.77_bib16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neurobiolaging.2004.03.009","article-title":"Calcium channel blockers and risk of AD: the Baltimore Longitudinal Study of Aging","volume":"26","author":"Yasar","year":"2005","journal-title":"Neurobiol Aging"},{"issue":"11","key":"10.14283\/jpad.2022.77_bib17","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1253\/circj.CJ-16-0692","article-title":"Calcium-Channel Blockers and Dementia Risk in Older Adults \u2014 National Health Insurance Service \u2014 Senior Cohort (2002\u20132013)","volume":"80","author":"Hwang","year":"2016","journal-title":"Circ J."},{"issue":"13","key":"10.14283\/jpad.2022.77_bib18","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1111\/1471-0528.15199","article-title":"Randomised controlled trials \u2014 the gold standard for effectiveness research: Study design: randomised controlled trials","volume":"125","author":"Hariton","year":"2018","journal-title":"BJOG"},{"issue":"9137","key":"10.14283\/jpad.2022.77_bib19","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(98)03086-4","article-title":"Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial","volume":"352","author":"Forette","year":"1998","journal-title":"Lancet"},{"issue":"8","key":"10.14283\/jpad.2022.77_bib20","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1474-4422(08)70143-1","article-title":"Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial","volume":"7","author":"Peters","year":"2008","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.14283\/jpad.2022.77_bib21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4103\/picr.picr_62_21","article-title":"Introduction to real-world evidence studies","volume":"12","author":"Chodankar","year":"2021","journal-title":"Perspect Clin Res"},{"issue":"6","key":"10.14283\/jpad.2022.77_bib22","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/cpt.512","article-title":"Real World Data in Adaptive Biomedical Innovation: A Framework for Generating Evidence Fit for Decision-Making","volume":"100","author":"Schneeweiss","year":"2016","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.14283\/jpad.2022.77_bib23","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1212\/WNL.0000000000008732","article-title":"Investigation of antihypertensive class, dementia, and cognitive decline: A meta-analysis","volume":"94","author":"Peters","year":"2020","journal-title":"Neurology"},{"issue":"4","key":"10.14283\/jpad.2022.77_bib24","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3233\/JAD-2011-111160","article-title":"No association between hypertension and risk for Alzheimer's disease: a meta-analysis of longitudinal studies","volume":"27","author":"Guan","year":"2011","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"10.14283\/jpad.2022.77_bib25","first-page":"289","article-title":"Sample size estimation in epidemiologic studies","volume":"2","author":"Hajian-Tilaki","year":"2011","journal-title":"Caspian J Intern Med"},{"issue":"2","key":"10.14283\/jpad.2022.77_bib26","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3233\/JAD-180288","article-title":"Does Treating Vascular Risk Factors Prevent Dementia and Alzheimer's Disease? A Systematic Review and Meta-Analysis","volume":"64","author":"Larsson","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"10.14283\/jpad.2022.77_bib27","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jclinepi.2005.11.010","article-title":"Single data extraction generated more errors than double data extraction in systematic reviews","volume":"59","author":"Buscemi","year":"2006","journal-title":"J Clin Epidemiol"},{"key":"10.14283\/jpad.2022.77_bib28","doi-asserted-by":"crossref","first-page":"105515","DOI":"10.1016\/j.phrs.2021.105515","article-title":"Association between renin-angiotensin-aldosterone system inhibitors and risk of dementia: A meta-analysis","volume":"166","author":"Scotti","year":"2021","journal-title":"Pharmacological Research"},{"key":"10.14283\/jpad.2022.77_bib29","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Bmj"},{"key":"10.14283\/jpad.2022.77_bib30","author":"Adesuyan"},{"key":"10.14283\/jpad.2022.77_bib31","author":"National Institute for Health and Care Excellence"},{"key":"10.14283\/jpad.2022.77_bib32","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"Bmj"},{"issue":"3","key":"10.14283\/jpad.2022.77_bib33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"issue":"7414","key":"10.14283\/jpad.2022.77_bib34","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ (Clinical research ed)"},{"issue":"20","key":"10.14283\/jpad.2022.77_bib35","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1212\/01.wnl.0000345062.86148.3f","article-title":"Duration of antihypertensive drug use and risk of dementia A prospective cohort study","volume":"72","author":"Haag","year":"2009","journal-title":"Neurology"},{"issue":"3","key":"10.14283\/jpad.2022.77_bib36","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0197-4580(00)00241-4","article-title":"Antihypertensive drugs and incidence of dementia: the Rotterdam Study","volume":"22","author":"in't Veld","year":"2001","journal-title":"Neurobiol Aging"},{"issue":"6","key":"10.14283\/jpad.2022.77_bib37","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1212\/WNL.0000000000002946","article-title":"Dementia risk with antihypertensive use and blood pressure variability","volume":"87","author":"Tully","year":"2016","journal-title":"Neurology"},{"issue":"11","key":"10.14283\/jpad.2022.77_bib38","first-page":"18","article-title":"The association of multiple anti-hypertensive medication classes with Alzheimer's disease incidence across sex, race, and ethnicity","volume":"13","author":"Berthold","year":"2018","journal-title":"PLoS One"},{"issue":"4","key":"10.14283\/jpad.2022.77_bib39","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/HJH.0000000000000086","article-title":"Angiotension receptor blockers reduce the risk of dementia","volume":"32","author":"Chiu","year":"2014","journal-title":"J Hypertens"},{"issue":"4","key":"10.14283\/jpad.2022.77_bib40","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3233\/JAD-2011-110347","article-title":"Associations of Anti-Hypertensive Treatments with Alzheimer's Disease, Vascular Dementia, and Other Dementias","volume":"26","author":"Davies","year":"2011","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"10.14283\/jpad.2022.77_bib41","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1253\/circj.CJ-12-0658","article-title":"Angiotensin-Receptor Blockers and Risk of Alzheimer's Disease in Hypertension Population \u2014 A Nationwide Cohort Study","volume":"77","author":"Hsu","year":"2013","journal-title":"Circ J."},{"key":"10.14283\/jpad.2022.77_bib42","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ijcard.2016.06.215","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers reduced dementia risk in patients with diabetes mellitus and hypertension","volume":"220","author":"Kuan","year":"2016","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.14283\/jpad.2022.77_bib43","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3233\/JAD-190362","article-title":"The Relationship Between the Use of Antihypertensive Drugs and the Incidence of Dementia in General Practices in Germany","volume":"70","author":"Bohlken","year":"2019","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"10.14283\/jpad.2022.77_bib44","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/bcp.12511","article-title":"Angiotensin receptor blockers and risk of dementia: Cohort study in UK Clinical Practice Research Datalink","volume":"79","author":"Goh","year":"2015","journal-title":"Br J Clin Pharmacol"},{"issue":"13","key":"10.14283\/jpad.2022.77_bib45","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1001\/archinternmed.2009.175","article-title":"Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study","volume":"169","author":"Sink","year":"2009","journal-title":"Arch Intern Med"},{"issue":"10","key":"10.14283\/jpad.2022.77_bib46","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1097\/HJH.0000000000001411","article-title":"Lower dementia risk with different classes of antihypertensive medication in older patients","volume":"35","author":"van Middelaar","year":"2017","journal-title":"J Hypertens"},{"key":"10.14283\/jpad.2022.77_bib47","unstructured":"eeks JJ HJ, Altman DG (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). 2022. Available from: www.training.cochrane.org\/handbook."},{"key":"10.14283\/jpad.2022.77_bib48","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/9781119413431.ch33","article-title":"The Use of Pharmacoepidemiology to Study Beneficial Drug Effects","author":"Strom","year":"2019","journal-title":"Pharmacoepidemiology"},{"key":"10.14283\/jpad.2022.77_bib49","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neurobiolaging.2020.12.011","article-title":"Associations between brain amyloid accumulation and the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers","volume":"100","author":"Ouk","year":"2021","journal-title":"Neurobiol Aging"},{"issue":"4","key":"10.14283\/jpad.2022.77_bib50","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S1474-4422(07)70077-7","article-title":"Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?","volume":"6","author":"Kehoe","year":"2007","journal-title":"The Lancet Neurology"},{"issue":"440","key":"10.14283\/jpad.2022.77_bib51","volume":"9","year":"2018","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"10.14283\/jpad.2022.77_bib52","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13195-016-0217-7","article-title":"Angiotensin-converting enzyme 2 is reduced in Alzheimer's disease in association with increasing amyloid-\u03b2 and tau pathology","volume":"8","author":"Kehoe","year":"2016","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"10.14283\/jpad.2022.77_bib53","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/jcbfm.2011.133","article-title":"Direct stimulation of angiotensin II type 2 receptor enhances spatial memory","volume":"32","author":"Jing","year":"2012","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.14283\/jpad.2022.77_bib54","series-title":"Introduction to meta-analysis","author":"Borenstein","year":"2021"},{"issue":"5","key":"10.14283\/jpad.2022.77_bib55","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/aje\/kwf074","article-title":"Risk Factors for Alzheimer's Disease: A Prospective Analysis from the Canadian Study of Health and Aging","volume":"156","author":"Lindsay","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.14283\/jpad.2022.77_bib56","doi-asserted-by":"crossref","first-page":"b5465","DOI":"10.1136\/bmj.b5465","article-title":"Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis","volume":"340","author":"Li","year":"2010","journal-title":"Bmj"},{"issue":"12","key":"10.14283\/jpad.2022.77_bib57","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1111\/j.1742-1241.2011.02810.x","article-title":"The association of antihypertensive medication use with risk of cognitive decline and dementia: a meta-analysis of longitudinal studies","volume":"65","author":"Chang-Quan","year":"2011","journal-title":"Int J Clin Pract"},{"issue":"1","key":"10.14283\/jpad.2022.77_bib58","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1474-4422(19)30393-X","article-title":"Antihypertensive medications and risk for incident dementia and Alzheimer's disease: a meta-analysis of individual participant data from prospective cohort studies","volume":"19","author":"Ding","year":"2020","journal-title":"The Lancet Neurology"},{"issue":"4","key":"10.14283\/jpad.2022.77_bib59","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/ije\/dyz155","article-title":"Repurposing antihypertensive drugs for the prevention of Alzheimer's disease: a Mendelian randomization study","volume":"49","author":"Walker","year":"2020","journal-title":"Int J Epidemiol"},{"issue":"7109","key":"10.14283\/jpad.2022.77_bib60","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"Bmj"},{"key":"10.14283\/jpad.2022.77_bib61","author":"Sterne"},{"issue":"6","key":"10.14283\/jpad.2022.77_bib62","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/jama.2018.21442","article-title":"Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial (SPRINT MIND TRIAL)","volume":"321","author":"Williamson","year":"2019","journal-title":"JAMA"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724002814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724002814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T02:11:31Z","timestamp":1737339091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580724002814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S2274580724002814"],"URL":"https:\/\/doi.org\/10.14283\/jpad.2022.77","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antihypertensive Agents and Incident Alzheimer's Disease: A Systematic Review and Meta-Analysis of Observational Studies","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jpad.2022.77","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}